OSCR Earnings & Financial Statements
Oscar Health, Inc.
$32.34
-$0.08(-0.25%)
61
Overall
60
Value
60
Tech
65
Quality
Market Cap
$10.01B
Volume
4.86M
52W Range
$10.69 - $34.48
Target Price
$35.40
OSCR earnings and financial statements: Oscar Health, Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
OSCR Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $11.70B | $9.18B | $5.86B | $4.13B | $1.84B |
| Operating income | -$396.36M | $57.27M | -$235.62M | -$589.87M | -$544.48M |
| Net income | -$443.15M | $25.43M | -$270.73M | -$606.27M | -$572.61M |
| EPS (diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $6.33B | $4.84B | $3.60B | $4.53B | $3.32B |
| Total liabilities | $5.34B | $3.82B | $2.80B | $3.63B | $1.93B |
| Shareholders’ equity | $977.65M | $1.01B | $803.97M | $890.38M | $1.39B |
| Cash and equivalents | $2.77B | $1.53B | $1.87B | $1.56B | $1.10B |
| Long-term debt | - | $299.56M | - | - | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $1.09B | $978.19M | -$272.16M | $380.35M | -$181.75M |
| Capital expenditure | - | -$27.90M | -$25.58M | -$29.01M | -$25.89M |
| Free cash flow | $1.06B | $950.30M | -$297.74M | $351.34M | -$207.63M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OSCR | $32.34 | -0.2% | 4.86M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |